Abstract
Recent work on computer vision and image processing has relied substantially on open datasets, which allow for an objective comparison of techniques and methodologies. In the area of computational pathology and, more specifically, on colorectal cancer, the dataset NCT-CRC-HE-100K, which consists of 100,000 patches of human tissue stained with Haematoxylin and Eosin has been widely used as a training set for deep learning studies. The patches are grouped into 9 classes of tissue (adipose, background, debris, lymphocytes, mucus, smooth muscle, normal colon mucosa, cancer-associated stroma, colorectal adenocarcinoma epithelium). The set is released with a separate set (CRC-VAL-HE-7K) of 7,180 patches that is commonly used for testing. In this work, features were extracted from both sets first with Persistent Homology, then, with Gabor filters to reveal that the training set presents a rather different distribution from the testing set. Namely, the distribution of features in the 7K-set presents a much higher class overlap than those in the 100K-set, which would imply a much higher separability in the testing set than in the training set.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Datasets were publicly availabe from Zotero: https://zenodo.org/records/1214456
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
daniel.brito{at}citystgeorges.ac.uk
Data Availability
All data produced are available online at https://zenodo.org/records/1214456
